This study looks at whether zongertinib, a targeted oral treatment, can help people with completely removed early-stage non-small cell lung cancer (NSCLC) that has specific HER2 mutations. The main goal is to see if zongertinib can help people stay healthy longer compared to standard treatments. Participants will be randomly assigned to receive either zongertinib or the usual care, which may include other medicines or observation, based on what their doctor advises.
This is a Phase 3 trial, meaning it is testing how well zongertinib works and its safety. The study aims to include about 400 participants and is regulated by the FDA.
Who can join
Adults aged 18 and older can join this trial. It is open to both men and women. Participants must have a confirmed diagnosis of NSCLC with specific HER2 mutations and have had surgery to remove their cancer. Some health conditions may prevent people from joining, so the trial team will check eligibility.
Condition
Non-small Cell Lung Cancer
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly divided into two groups. One group will take zongertinib daily for up to 3 years. The other group will receive standard treatment, which could include approved immunotherapy or just careful monitoring, depending on local practices.
Where
This trial is enrolling at 29 locations. Recruiting sites are listed first.
Cancer Care Specialists
Reno, Nevada
Recruiting
ClinRé 001-022 (Premier Cancer Care and Infusion Center)
Fresno, California
Recruiting
Community Cancer Trials of Utah
Ogden, Utah
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts
Recruiting
Hendrick Health
Abilene, Texas
Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
Chief of Thoracic Surgery and Director of the Lung Cancer Program at West Virginia University Cancer Institute. Treats lung cancer and esophageal cancer.
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Led the National Lung Screening Trial. Treats lung cancer. Other doctors who help with cancer care, like gastroenterologists, dermatologists, and endocrinologists. Recognized at state, national or international level.